GB1478082A - Process for obtaining antigens from schistosomes agent containing these antigens and its use - Google Patents

Process for obtaining antigens from schistosomes agent containing these antigens and its use

Info

Publication number
GB1478082A
GB1478082A GB1734675A GB1734675A GB1478082A GB 1478082 A GB1478082 A GB 1478082A GB 1734675 A GB1734675 A GB 1734675A GB 1734675 A GB1734675 A GB 1734675A GB 1478082 A GB1478082 A GB 1478082A
Authority
GB
United Kingdom
Prior art keywords
antigens
schistosomes
agent containing
obtaining
way
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1734675A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Publication of GB1478082A publication Critical patent/GB1478082A/en
Expired legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0003—Invertebrate antigens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GB1734675A 1974-04-29 1975-04-25 Process for obtaining antigens from schistosomes agent containing these antigens and its use Expired GB1478082A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2420706A DE2420706C3 (de) 1974-04-29 1974-04-29 Verfahren zum Herstellen von spezifischen Antigenen aus Schistosomen und jene enthaltendes Mittel

Publications (1)

Publication Number Publication Date
GB1478082A true GB1478082A (en) 1977-06-29

Family

ID=5914244

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1734675A Expired GB1478082A (en) 1974-04-29 1975-04-25 Process for obtaining antigens from schistosomes agent containing these antigens and its use

Country Status (16)

Country Link
JP (1) JPS50145518A (enExample)
AT (1) AT344329B (enExample)
BE (1) BE828565A (enExample)
CA (1) CA1052694A (enExample)
CH (1) CH617775A5 (enExample)
DE (1) DE2420706C3 (enExample)
DK (1) DK140044C (enExample)
EG (1) EG12734A (enExample)
ES (1) ES436866A1 (enExample)
FR (1) FR2268532B1 (enExample)
GB (1) GB1478082A (enExample)
IE (1) IE41024B1 (enExample)
IT (1) IT1049537B (enExample)
LU (1) LU72375A1 (enExample)
NL (1) NL7504853A (enExample)
ZA (1) ZA752717B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2356428A1 (fr) * 1976-06-29 1978-01-27 Inserm Ctre Technologie Biomed Procede de preparation d'un agent immunologique antiparasitaire, produit obtenu et son application
FR2601037B1 (fr) * 1986-07-03 1988-10-21 Pasteur Institut Peptide presentant des proprietes antigeniques isole de la proteine 28 kd de s. mansoni et son procede d'isolement, anticorps monoclonaux reconnaissant au moins un epitope dudit peptide et application de celui-ci dans l'induction de la synthese d'anticorps neutralisants
KR20230092004A (ko) * 2020-10-27 2023-06-23 메르크 파텐트 게엠베하 쉬스토소마 감염의 검출을 위한 단백질

Also Published As

Publication number Publication date
DK184575A (da) 1975-10-30
FR2268532B1 (enExample) 1980-01-25
IE41024B1 (en) 1979-10-10
DE2420706C3 (de) 1979-11-22
ZA752717B (en) 1976-03-31
DE2420706A1 (de) 1975-10-30
FR2268532A1 (enExample) 1975-11-21
DK140044B (da) 1979-06-11
ATA325475A (de) 1977-11-15
CA1052694A (en) 1979-04-17
JPS50145518A (enExample) 1975-11-21
NL7504853A (nl) 1975-10-31
IT1049537B (it) 1981-02-10
LU72375A1 (enExample) 1977-02-03
DK140044C (da) 1979-11-12
IE41024L (en) 1975-10-29
DE2420706B2 (de) 1979-03-22
AT344329B (de) 1978-07-10
BE828565A (fr) 1975-10-29
CH617775A5 (en) 1980-06-13
EG12734A (en) 1979-06-30
ES436866A1 (es) 1977-01-01

Similar Documents

Publication Publication Date Title
BE840616A (fr) Dispositif pour la sterilisation par coagulation transuterine du tissu entre les oviductes et l'uterus
SE373279B (sv) Forfarande och anordning for undersokning av en del av en biologisk vevnad
ES8200082A1 (es) Procedimiento para esterilizar un agente de contraste de ra-yos x de m-carboxamido-o-yodo-n-(b-hidroxialcohil)-anilina.
ES398962A1 (es) Un procedimiento para la preparacion de una composicion de enzima.
JPS5549393A (en) Novel tissue protein pp8
ES379641A1 (es) Procedimiento de produccion de antigenos inactivos para preparados farmaceuticos.
MX157054A (es) Procedimiento para preparar derivados de disenzoxazepina
GB1478082A (en) Process for obtaining antigens from schistosomes agent containing these antigens and its use
Herxheimer et al. Weal and flare in human skin produced by histamine and other substances
SE408412B (sv) Forfarande for framstellning av l-3-(3,4-dihydroxi-fenyl)-2-metyl-alanin-peptider med blodtryckssenkande egenskaper
Seidel The life cycle in vitro of Hymenolepis microstoma (Cestoda)
SE7510775L (sv) Fenoxialkankarbonsyraamider och forfarande for framstellning derav
FI99114B (fi) Menetelmä tyvikalvoproteiinien eristämiseksi ihmis- ja eläinkudoksista
EP0280135A3 (en) Protein c-inhibitor (pci) as a pharmaceutical and diagnostic agent, process for the preparation of such a pharmaceutical or diagnostic agent and a composition containing pci
Carrel An Address On The Method Of Tissue Culture And Its Bearing On Pathological Problems
FR2423223A1 (fr) Vaccin et dose a injecter pour l'immunotherapie d'une maladie neoplasique
ATE92760T1 (de) Verwendung des thiazol-derivates tiprotimod zur herstellung eines mittels zur therapie von virusinfektionen.
GB806950A (en) Production of pharmaceutical preparations
LEVINE et al. Streptobacillus moniliformis bacteremia with minor clinical manifestations
SU147554A1 (ru) Способ диагностики инфекционного атрофического ринита свиней
FR1369334A (fr) Procédé de préparation d'un matériel virulent contenant le virus de la fièvre aphteuse
KE2550A (en) Process for the bulk culture of foot and mouth disease viruses
Robertson et al. A note on the rectal instillation of rabies material into Syrian hamsters
BE815777A (fr) Produit pour le traitement medical des maladies infectieuses en particulier pour les maladies virulentes en medecine humaine et animale
DK477180A (da) Vaccine og fremgangsmaade til fremstilling heraf

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee